» Articles » PMID: 34541298

Molecular Level Dissection of Critical Spike Mutations in SARS-CoV-2 Variants of Concern (VOCs): A Simplified Review

Overview
Journal ChemistrySelect
Specialty Chemistry
Date 2021 Sep 20
PMID 34541298
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 virus during its spread in the last one and half year has picked up critical changes in its genetic code i.e. mutations, which have leads to deleterious epidemiological characteristics. Due to critical role of spike protein in cell entry and pathogenesis, mutations in spike regions have been reported to enhance transmissibility, disease severity, possible escape from vaccine-induced immune response and reduced diagnostic sensitivity/specificity. Considering the structure-function impact of mutations, understanding the molecular details of these key mutations of newly emerged variants/lineages is of urgent concern. In this review, we have explored the literature on key spike mutations harbored by , , and 'variants of concern' (VOCs) and discussed their molecular consequences in the context of resultant virus biology. Commonly all these VOCs i.e. and lineages have decisive mutation in Receptor Binding Motif (RBM) region and/or region around Furin cleavage site (FCS) of spike protein. In general, mutation induced disruption of -molecular interaction enhances molecular flexibility leading to exposure of spike protein surface in these lineages to make it accessible for -molecular interaction with hACE2. A disruption of spike antigen-antibody -molecular interactions in epitope region due to the chemical nature of substituting amino acid hampers the neutralization efficacy. Simplified surveillance of mutation induced changes and their consequences at molecular level can contribute in rationalizing mutation's impact on virus biology. It is believed that molecular level dissection of these key spike mutation will assist the future investigations for a more resilient outcome against severity of COVID-19.

Citing Articles

Association of COVID with Mycosis in General.

Kaur G, Kaur R, Sumanpreet , Kaur M Infect Disord Drug Targets. 2024; 24(6):e190124225866.

PMID: 38251692 DOI: 10.2174/0118715265266815231130063931.


Defining neutralization and allostery by antibodies against COVID-19 variants.

Tulsian N, Palur R, Qian X, Gu Y, DO Shunmuganathan B, Samsudin F Nat Commun. 2023; 14(1):6967.

PMID: 37907459 PMC: 10618280. DOI: 10.1038/s41467-023-42408-x.


Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India.

Gopalan V, Chandran A, Arumugam K, Sundaram M, Velladurai S, Govindan K J Glob Infect Dis. 2023; 15(2):43-51.

PMID: 37469462 PMC: 10353649. DOI: 10.4103/jgid.jgid_178_22.


Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection.

Yang H, Chen Y, Jiang D, Feng X, Xu Y, Wei J Antib Ther. 2023; 6(2):97-107.

PMID: 37077474 PMC: 10108555. DOI: 10.1093/abt/tbad003.


Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients.

Giotis E, Cil E, Brooke G Viruses. 2022; 14(12).

PMID: 36560732 PMC: 9788624. DOI: 10.3390/v14122728.


References
1.
Xue T, Wu W, Guo N, Wu C, Huang J, Lai L . Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by affinity maturation and SPR assay. RSC Adv. 2022; 11(24):14737-14745. PMC: 8697837. DOI: 10.1039/d1ra00426c. View

2.
Faria N, Mellan T, Whittaker C, Claro I, Candido D, Mishra S . Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021; 372(6544):815-821. PMC: 8139423. DOI: 10.1126/science.abh2644. View

3.
Srivastava S, Banu S, Singh P, Sowpati D, Mishra R . SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants. J Biosci. 2021; 46. PMC: 7895735. View

4.
Khoury D, Cromer D, Reynaldi A, Schlub T, Wheatley A, Juno J . Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021; 27(7):1205-1211. DOI: 10.1038/s41591-021-01377-8. View

5.
Joshi M, Puvar A, Kumar D, Ansari A, Pandya M, Raval J . Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology. Front Genet. 2021; 12:586569. PMC: 8017293. DOI: 10.3389/fgene.2021.586569. View